← back to search

Clarence C. Tam

National University of Singapore · SG
Area of research
Infectious Diseases · Modeling and Simulation
Research interest
Research interests include Viral gastroenteritis research and epidemiology, COVID-19 epidemiological studies, Mosquito-borne diseases and control, and Vaccine Coverage and Hesitancy.
h-index
42
citations
6,633
works
157
NIH funding
primary concept
Medicine
email

Recent publications

Maternal vaccination decision-making in urban and rural Bengaluru, India: A mixed methods study.
2025cited by 0position: contributordoi
Estimating public health risks of infectious disease events: A Canadian approach to rapid risk assessment.
2024cited by 1position: contributordoi
Determinants of influenza and pneumococcal vaccine uptake among preschool children in Singapore
PLoS ONE 2023cited by 5position: lastdoi
Determinants of influenza and pneumococcal vaccine uptake among preschool children in Singapore.
2023cited by 5position: contributordoi
Understanding networks in rural Cambodian farming communities and how they influence antibiotic use: A mixed methods study.
2023cited by 2position: contributordoi
Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey
International Journal of Infectious Diseases 2022cited by 12position: lastdoi
Dengue Endemicity, Force of Infection, and Variation in Transmission Intensity in 13 Endemic Countries.
2022cited by 11position: contributordoi
Contrasting SARS-CoV-2 epidemics in Singapore: cohort studies in migrant workers and the general population.
2022cited by 8position: contributordoi
Adolescent girls' recommendations for the design of a human papillomavirus vaccination program in Sindh, Pakistan: a qualitative study.
2022cited by 7position: contributordoi
A country-specific model of COVID-19 vaccination coverage needed for herd immunity in adult only or population wide vaccination programme
Epidemics 2022cited by 5position: middledoi
Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey.
2022cited by 5position: contributordoi
Factors associated with maternal tetanus vaccination in Myanmar: An analysis of demographic and health survey data
Vaccine 2022cited by 3position: lastdoi
A country-specific model of COVID-19 vaccination coverage needed for herd immunity in adult only or population wide vaccination programme.
2022cited by 3position: contributordoi
COVID-19 differentiated measures for unvaccinated individuals: The need for clear goals and strong justifications.
2022cited by 2position: contributordoi
SARS-CoV-2 neutralising antibody activity in a highly vaccinated population: Longitudinal serology studies in Singapore
2022cited by 0position: contributordoi
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
The Journal of Experimental Medicine 2021cited by 341position: lastdoi
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.
2021cited by 265position: contributordoi
The effects of maximum ambient temperature and heatwaves on dengue infections in the tropical city-state of Singapore – A time series analysis
The Science of The Total Environment 2021cited by 57position: lastdoi
Population anxiety and positive behaviour change during the COVID-19 epidemic: Cross-sectional surveys in Singapore, China and Italy.
2021cited by 36position: contributordoi
The effects of maximum ambient temperature and heatwaves on dengue infections in the tropical city-state of Singapore - A time series analysis.
2021cited by 32position: contributordoi
Public knowledge, attitudes and practices related to antibiotic use and resistance in Singapore: a cross-sectional population survey
BMJ Open 2021cited by 30position: lastdoi
Public knowledge, attitudes and practices surrounding antibiotic use and resistance in Cambodia
JAC-Antimicrobial Resistance 2021cited by 23position: lastdoi
Widely heterogeneous humoral and cellular immunity after mild SARS-CoV-2 infection in a homogeneous population of healthy young men.
2021cited by 23position: contributordoi
Immunity certification for COVID-19: ethical considerations.
2021cited by 20position: contributordoi
Contrasting SARS-CoV-2 epidemics in Singapore: cohort studies in migrant workers and the general population
International Journal of Infectious Diseases 2021cited by 10position: lastdoi
Ward-level factors associated with methicillin-resistant Staphylococcus aureus acquisition–an electronic medical records study in Singapore
PLoS ONE 2021cited by 5position: lastdoi
Public perception of ethical issues related to COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey
2021cited by 2position: contributordoi
Factors associated with maternal tetanus vaccination in Myanmar: An analysis of Demographic and Health Survey data
2021cited by 0position: contributordoi
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study
The Lancet Infectious Diseases 2020cited by 829position: middledoi
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study.
2020cited by 447position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 14 papers (2020–2022)Li Yang Hsu · Fred Hutch Cancer Center13 papers (2017–2023)Vittoria Offeddu · National University of Singapore8 papers (2016–2023)Chee Fu Yung · Nanyang Technological University7 papers (2016–2022)Teck Chuan Voo · National University of Singapore7 papers (2019–2022)Jane Mingjie Lim · National University of Singapore7 papers (2019–2022)Alex R. Cook · National University of Singapore6 papers (2019–2021)Zaw Myo Tun · National University Health System6 papers (2020–2022)Zaw Myo Tun · National University of Singapore5 papers (2016–2022)Mabel Sheau Fong Low · Centers for Disease Control and Prevention4 papers (2016–2019)Laura C. Rodrigues · London School of Hygiene & Tropical Medicine4 papers (2012–2016)Helena Legido‐Quigley · National University of Singapore4 papers (2016–2019)Jane M. Lim · Changi General Hospital4 papers (2020–2021)Joshua Nealon · Sanofi (France)4 papers (2018–2020)Hannah Clapham · National University of Singapore4 papers (2020–2022)Nivedita Shankar · National University of Singapore3 papers (2017–2021)Benjamin J. Cowling · Laboratory of Data Discovery for Health3 papers (2020–2022)Minh Cam Duong · National University of Singapore3 papers (2019–2021)Teck Chuan Voo · SingHealth3 papers (2020–2022)Bryan T. Grenfell · Princeton University2 papers (2020–2020)